NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker declared a quarterly dividend on Monday, August 13th. Stockholders of record on Tuesday, September 4th will be given a dividend of $0.04 per share on Friday, September 21st. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend is Friday, August 31st. View Bruker's Dividend History.

Bruker announced that its Board of Directors has approved a stock repurchase plan on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings results on Thursday, August, 2nd. The medical research company reported $0.25 earnings per share for the quarter, meeting the consensus estimate of $0.25. The medical research company had revenue of $443.70 million for the quarter, compared to analyst estimates of $436.10 million. Bruker had a net margin of 4.99% and a return on equity of 27.03%. The company's revenue was up 6.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.23 earnings per share. View Bruker's Earnings History.

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, November 1st 2018. View Earnings Estimates for Bruker.

Bruker will be holding an earnings conference call on Thursday, November 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8884372685.

Bruker updated its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share guidance of $1.34-1.38 for the period, compared to the Thomson Reuters consensus estimate of $1.38. The company issued revenue guidance of approx $1.88 billion, compared to the consensus revenue estimate of $1.88 billion.

9 brokerages have issued 12 month price targets for Bruker's shares. Their predictions range from $28.00 to $42.00. On average, they anticipate Bruker's share price to reach $33.8889 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price. View Analyst Price Targets for Bruker.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker.

Some companies that are related to Bruker include Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Coherent (COHR), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Eyepoint Pharmaceuticals (EYPT), HTG Molecular Diagnostics (HTGM), BioNano Genomics (BNGO), Arrayit (ARYC) and Aethlon Medical (AEMD).

Bruker's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include MERIAN GLOBAL INVESTORS UK Ltd (0.45%), Scout Investments Inc. (0.12%), Bank of Montreal Can (0.04%), Cornerstone Wealth Management LLC (0.02%), Fox Run Management L.L.C. (0.01%) and Seven Eight Capital LP (0.01%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Fox Run Management L.L.C. and Strs Ohio. View Insider Buying and Selling for Bruker.

BRKR stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Seven Eight Capital LP, Nisa Investment Advisors LLC, First Hawaiian Bank, Scout Investments Inc., Cornerstone Wealth Management LLC and Ramsey Quantitative Systems. View Insider Buying and Selling for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $30.66.

Bruker has a market capitalization of $4.91 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

The official website for Bruker is http://www.bruker.com.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]